NEU_INS_STIMULATOR

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,l report with the FDA on 2017-06-08 for NEU_INS_STIMULATOR manufactured by Medtronic Neuromodulation.

Event Text Entries

[77231677] Please note that this date is based off of the date of publication of the article as the event dates were not provided in the published literature. The device was used for an off label indication. A good faith effort will be made to obtain the applicable information relevant to the report. If information is provided in the future, a supplemental report will be issued.
Patient Sequence No: 1, Text Type: N, H10


[77231678] Lim, lh. , noma fitzrol, d. , rajapathy, sk. , tan, yc. , sanihah, ah. , kandasamy, r. , wan hassan, wmn. , badrisyah, i. , abdul rahman izaini, g. , zamzuri, i. , tharakan, j. , nunta-aree, s. , jafri malin, a. Deep brain stimulation (dbs) for movement disorders: an experience in hospital universiti sains malaysia (husm) involving 12 patients. Malaysian journal of medical sciences. 2017;24(2):87-93. Doi: 10. 21315/mjms2017. 24. 2. 11. Summary: deep brain stimulation (dbs) was first introduced in 1987 to the developed world. As a developing country malaysia begun its movement disorder program by doing ablation therapy using the radionics system. Hospital universiti sains malaysia a rural based teaching hospital had to take into consideration both health economics and outcomes in the area that it was providing neurosurgical care for when it initiated its deep brain stimulation program. Most of the patients were from the low to medium social economic groups and could not afford payment for a dbs implant. We concentrated our dbs services to parkinson's disease, tourette's syndrome and dystonia patients who had exhausted medical therapy. The case series of these patients and their follow-up are presented in this brief communication. Reported events: 1. Case 12: a (b)(6) male with deep brain stimulation (dbs) of the medial thalamus for tourette? S syndrome experienced an allergic reaction to the device shortly after implant so the device was removed. It was not possible to ascertain specific device information from the article or to match the reported event with any previously reported event.
Patient Sequence No: 1, Text Type: D, B5


[100188147] If information is provided in the future, a supplemental report will be issued.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3007566237-2017-02268
MDR Report Key6624659
Report SourceFOREIGN,HEALTH PROFESSIONAL,L
Date Received2017-06-08
Date of Report2017-06-08
Date of Event2017-04-14
Date Mfgr Received2017-05-17
Date Added to Maude2017-06-08
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactLISA WOODWARD CLARK
Manufacturer Street7000 CENTRAL AVENUE NE RCW215
Manufacturer CityMINNEAPOLIS MN 55432
Manufacturer CountryUS
Manufacturer Postal55432
Manufacturer Phone7635263920
Manufacturer G1MEDTRONIC NEUROMODULATION
Manufacturer Street800 53RD AVE NE
Manufacturer CityMINNEAPOLIS MN 554211200
Manufacturer CountryUS
Manufacturer Postal Code554211200
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Product CodeMFR
Date Received2017-06-08
Model NumberNEU_INS_STIMULATOR
Catalog NumberNEU_INS_STIMULATOR
Lot NumberUNKNOWN
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerMEDTRONIC NEUROMODULATION
Manufacturer Address800 53RD AVE NE MINNEAPOLIS MN 554211200 US 554211200


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2017-06-08

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.